# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615290 | F | In vitro inhibition of 2780/DOX ovarian cancer cell line | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
2. | ALA884522 | F | In vitro inhibition of 2780/S ovarian cancer cell line | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
3. | ALA619116 | F | In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
4. | ALA619117 | F | In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C for 96 hr | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
5. | ALA619118 | F | Compound was evaluated for cytotoxicity against A2780 cell lines. | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
6. | ALA619119 | F | Potentiation of growth inhibition of A2780 by compound alone in experiment 1 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA619120 | F | Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA619121 | F | Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
9. | ALA619122 | F | Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
10. | ALA619123 | F | Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
11. | ALA619124 | F | Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
12. | ALA619125 | F | Compound was evaluated for cytotoxicity against A2780 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA875411 | F | In vitro inhibitory activity against human tumor cell line A2780 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA619126 | F | Potentiation of growth inhibition of A2780 cells by compound alone in experiment 1 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
15. | ALA619127 | F | Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA619128 | F | Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA619129 | F | Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
18. | ALA619130 | F | The compound was tested for cytotoxic potency against A2780 human tumor cell lines | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
19. | ALA619131 | F | The compound was tested for cytotoxic potency against A2780 human tumor cell lines. | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
20. | ALA619132 | F | cytotoxicity against A2780 cells incubated for 24 hr in MTT assay. | Homo sapiens | 8 | cell-based format | Scientific Literature |